NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Again, I do not believe NWBO presented at ASCO with retail in mind. In fact, it could be they were trying to shake some retail. I think their target audiences were regulators and BP. Think about it. Dr. Bosch could have simply shared SNO conference data plus another three months, and the stock would have increased.

People forget that Dr. Ashkan was not presenting at this conference. Remember, Dr. Bosch was the one that wanted to wait at the last ASCO while Dr. Ashkan stated he would ask every day to unblind the trial.

Dr. Bosch still appears to be the voice of "wait," while the other voice was not represented on Sunday.